PINK Simplify Health Care ETF

ETF on NYSE (US) · Actively managed · Listing

Daily holdings file Nov 17, 2026 Published at simplify.us
Book $335M 54 positions
Line items 54
In top 10 58%
Largest holding: United Therapeutics Corporation ($32.8M) 9.8%
Portfolio date Nov 17, 2026

Changes appear once four weeks of holdings are on file.

Largest holding: United Therapeutics Corporation, 56,237 shares ($32.8M).

United Therapeutics Corporation: 9.8% Arcutis Biotherapeutics, Inc.: 8.8% Johnson & Johnson: 7.9% Eli Lilly and Company: 5.6% Humana Inc.: 5.1% Warby Parker Inc.: 4.6% AbbVie Inc.: 4.3% Gilead Sciences, Inc.: 3.9% Avantor, Inc.: 3.9% Jazz Pharmaceuticals plc: 3.7% The other 44 positions: 42.3% $335M Holdings value
Current positions Top 10 % of book
United Therapeutics Corporation UTHR $32.8M 9.8%
Arcutis Biotherapeutics, Inc. ARQT $29.5M 8.8%
Johnson & Johnson JNJ $26.4M 7.9%
Eli Lilly and Company LLY $18.7M 5.6%
Humana Inc. HUM $17.0M 5.1%
Warby Parker Inc. WRBY $15.5M 4.6%
AbbVie Inc. ABBV $14.5M 4.3%
Gilead Sciences, Inc. GILD $13.2M 3.9%
Avantor, Inc. AVTR $13.0M 3.9%
Jazz Pharmaceuticals plc JAZZ $12.4M 3.7%

Slices are % of holdings value.

Healthcare: 86.7% Consumer Cyclical: 4.6% Industrials: 4.0% Basic Materials: 1.7% Technology: 1.0% Unclassified: 2.0% 5 sectors
Sectors % of holdings value
Healthcare 86.7%
Consumer Cyclical 4.6%
Industrials 4.0%
Basic Materials 1.7%
Technology 1.0%
Unclassified 2.0%
Biotechnology: 42.5% Drug Manufacturers - General: 17.8% Healthcare Plans: 10.5% Diagnostics & Research: 5.7% Medical Devices: 5.5% Specialty Retail: 4.6% Industrial Distribution: 3.9% Other (5): 7.5% Unclassified: 2.0% 12 industries
Industries % of holdings value
Biotechnology 42.5%
Drug Manufacturers - General 17.8%
Healthcare Plans 10.5%
Diagnostics & Research 5.7%
Medical Devices 5.5%
Specialty Retail 4.6%
Industrial Distribution 3.9%
Other (5) 7.5%
Unclassified 2.0%

Source: the fund's own published holdings, the portfolio of Nov 17, 2026 (simplify.us). Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.

Objective

The Simplify Health Care ETF (the "Fund" or "PINK") seeks long-term capital appreciation.

Principal investment strategies

The Fund has adopted a non-fundamental policy that, under normal circumstances, the Fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The Fund defines health care companies as companies included in the Global Industry Classification Standard health care sector. The Fund defines equity securities as common stock, preferred stock, or ETFs that invest in the same. The Fund invests in companies without restriction as to capitalization, including micro-capitalization companies. 1 The Fund will invest in 50 to 100 health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities. In general, the Fund will follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however, a "value" approach, which gives preference to seemingly undervalued companies, may be emphasized. The Fund generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems. The Fund may invest in health care companies that do not seek to design or develop treatments for breast cancer. The Adviser may invest in affiliated money market ETFs to manage liquidity. The Fund may invest in repurchase agreements. Repurchase agreements are transactions in which the Fund purchases government securities and simultaneously commits to resell them to the same counterparty at a future time and at a price reflecting a market rate of interest. The Fund's namesake is The Susan G. Komen Breast Cancer Foundation, Inc. (the "Foundation"), a 501(c)(3) charitable foundation. In exchange for the use of its name and logo, Simplify Asset Management Inc., the Fund's investment adviser, will donate its annual management fee for managing the Fund to the Foundation. The Foundation shall use such donation to support its mission, but the Foundation will not participate in or have any influence on the day-to-day operations of the Fund or the Adviser's management of the Fund. The Fund is not organized as a charitable investment trust.

Management and Contact

Adviser
Simplify Asset Management Inc.
Portfolio managers

Michael Taylor, Portfolio Manager of the Adviser;

David Berns, PhD, Chief Investment Officer of the Adviser; and Jeff Schwarte, Chief Equity Strategist of the Adviser each serve as a portfolio manager of the Fund.

Mr. Taylor and Dr. Berns have each served the Fund as a portfolio manager since it commenced operations in October 2021.

Mr. Schwarte has served the Fund as portfolio manager since November 2024.

Mr. Taylor, Dr. Berns, and Mr. Schwarte are jointly and primarily responsible for the management of the Fund.

Phone
(855) 772-8488

Track Record as of Dec 31, 2025

1 Year Since Inception
Return Before Taxes 24.07% 10.05%
Return After Taxes on Distributions 23.68% 9.80%
Return After Taxes on Distributions and Sale of Fund Shares 14.22% 7.80%
MSCI USA IMI/Health Care Net (USD) Index (reflects no deduction for fees, expenses or taxes) 14.91% 4.76%
S&P 500 Index (reflects no deduction for fees, expenses or taxes) 17.88% 12.66%

Holdings as of Nov 17, 2026

54 lines, 53 linked, weights sum to 100.00% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
UNITED THERAPEUTICS CORP D USD 0.01 UTHR US91307C1027 Equity 56,237 0 9.81% $ 32.848M
ARCUTIS BIOTHERAPEUTICS USD 0.0001 ARQT US03969K1088 Equity 1,077,695 0 8.80% $ 29.453M
JOHNSON + JOHNSON USD 1.0 JNJ US4781601046 Equity 94,658 0 7.88% $ 26.381M
LILLY ELI + CO NPV LLY US5324571083 Equity 13,210 0 5.59% $ 18.699M
HUMANA INC USD 0.166667 HUM US4448591028 Equity 38,405 0 5.09% $ 17.026M
WARBY PARKER INC USD 0.0001 WRBY US93403J1060 Equity 599,545 0 4.64% $ 15.54M
ABBVIE INC USD 0.01 ABBV US00287Y1091 Equity 49,605 0 4.34% $ 14.525M
GILEAD SCIENCES INC USD 0.001 GILD US3755581036 Equity 77,477 0 3.94% $ 13.191M
AVANTOR INC USD 0.01 AVTR US05352A1007 Equity 859,446 0 3.90% $ 13.046M
JAZZ PHARMACEUTICALS PLC USD 0.0001 JAZZ IE00B4Q5ZN47 Equity 51,406 0 3.70% $ 12.374M
QUEST DIAG COM USD0.01 DGX US74834L1008 Equity 47,346 0 3.63% $ 12.137M
BENITEC BIOPHARMA INC NPV BNTC US08205P2092 Equity 1,398,956 0 3.41% $ 11.401M
AMGEN INC USD 0.0001 AMGN US0311621009 Equity 20,014 0 2.74% $ 9.165M
UNITEDHEALTH GROUP INC USD 0.01 UNH US91324P1021 Equity 21,693 0 2.53% $ 8.453M
GE HEALTHCARE TECHNOLOGIES USD 0.01 GEHC US36266G1076 Equity 89,245 0 2.18% $ 7.304M
SUMMIT THERAPEUTICS INC USD 0.01 SMMT US86627T1088 Equity 682,491 0 2.18% $ 7.282M
CARDINAL HEALTH INC NPV CAH US14149Y1082 Equity 25,646 0 2.14% $ 7.162M
BIOHAVEN LTD NPV BHVN VGG1110E1079 Equity 526,293 0 2.08% $ 6.968M
Cash
CASH Cash 6,706,454.9401 +2,883,130.0322 2.00% $ 6.706M
GUARDANT HEALTH INC USD 0.00001 GH US40131M1099 Equity 46,576 0 1.99% $ 6.673M
CVS HEALTH CORPORATION USD 0.01 CVS US1266501006 Equity 66,252 0 1.70% $ 5.685M
PURECYCLE TECHNOLOGIES I USD 0.0001 PCT US74623V1035 Equity 3,178,831 0 1.69% $ 5.658M
THERMO FISHER SCIENTIFIC IN USD 1.0 TMO US8835561023 Equity 8,068 0 1.66% $ 5.541M
VERTEX PHARMACEUTICALS INC USD 0.01 VRTX US92532F1003 Equity 9,980 0 1.59% $ 5.331M
ESTABLISHMENT LABS HOLDINGS USD 1.0 ESTA VGG312491084 Equity 57,661 0 1.20% $ 4.008M
COOPER COS INC USD 0.1 COO US2166485019 Equity 57,659 0 1.05% $ 3.501M
PRAXIS PRECISION MEDICIN USD 0.0001 PRAX US74006W2070 Equity 10,943 0 1.00% $ 3.338M
VEEVA SYS INC USD 0.00001 VEEV US9224751084 Equity 11,212 0 0.97% $ 3.234M
VAXCYTE INC USD 0.001 PCVX US92243G1085 Equity 53,169 0 0.94% $ 3.158M
SCHEIN HENRY INC USD 0.01 HSIC US8064071025 Equity 36,319 0 0.90% $ 3.012M
LEGEND BIOTECH CORP USD 0.0001 ADR LEGN US52490G1022 Equity 186,947 0 0.90% $ 3.012M
ELEVANCE HEALTH INC USD 0.01 ELV US0367521038 Equity 6,911 0 0.90% $ 2.999M
DANAHER CORP USD 0.01 DHR US2358511028 Equity 9,089 0 0.61% $ 2.052M
EDWARDS LI COM USD1 EW US28176E1082 Equity 17,801 0 0.56% $ 1.877M
TG THERAPEUTICS INC USD 0.001 TGTX US88322Q1085 Equity 20,283 0 0.38% $ 1.272M
AGILON HEALTH INC USD 0.01 AGL US00857U2069 Equity 8,038 0 0.28% $ 925.978K
STRYKER CORP USD 0.1 SYK US8636671013 Equity 2,148 0 0.20% $ 682.076K
FULCRUM THERAPEUTICS INC USD 0.001 FULC US3596161097 Equity 146,506 0 0.16% $ 549.398K
NEUROCRINE BIOSCIENCES IN USD 0.001 NBIX US64125C1099 Equity 3,162 0 0.16% $ 524.639K
ZIMMER BIOMET HLDGS INC USD 0.01 ZBH US98956P1021 Equity 4,191 0 0.13% $ 427.859K
ABBOTT LABS NPV ABT US0028241000 Equity 3,243 0 0.10% $ 339.575K
FLUOR CORP NEW USD 0.01 FLR US3434121022 Equity 5,944 0 0.09% $ 287.155K
ICON PLC EUR 0.06 ICLR IE0005711209 Equity 1,431 0 0.08% $ 279.074K
TELEFLEX INC USD 1.0 TFX US8793691069 Equity 1,401 0 0.07% $ 223.53K
SAREPTA THERAPEUTICS INC USD 0.0001 SRPT US8036071004 Equity 7,336 0 0.03% $ 108.353K
VERALTO CORP USD 0.01 VLTO US92338C1036 Equity 734 0 0.03% $ 86.891K
REGENERON PHARMACEUTICALS USD 0.001 REGN US75886F1075 Equity 78 0 0.02% $ 74.705K
BRISTOL MYERS SQUIBB CO USD 0.1 BMY US1101221083 Equity 1,049 0 0.02% $ 64.356K
GRAIL INC USD 0.01 GRAL US3847471014 Equity 478 0 0.02% $ 50.611K
ABIVAX SA EUR 0.01 ADR ABVX US00370M1036 Equity 220 0 0.01% $ 18.062K
INSMED INC USD 0.01 INSM US4576693075 Equity 148 0 0.01% $ 18.035K
EMBECTA CORP USD 0.01 EMBC US29082K1051 Equity 2,794 0 0.01% $ 17.183K
NOVO-NORDISK A S DKK 10.0 ADR NVO US6701002056 Equity 351 0 0.00% $ 14.286K
SYNDAX PHARMACEUTICALS I USD 0.0001 SNDX US87164F1057 Equity 774 0 0.00% $ 7,120.80

Trades Nov 16, 2026 to Nov 17, 2026

Holding Ticker Action Before After Change Value
PACIRA BIOSCIENCES INC USD 0.001 PCRX Closed 79,150 — −79,150 $ -2.887M

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up